Evolent Health Inc Class A (EVH)

New York Stock Exchange:
EVH
| Latest update: Mar 1, 2026, 8:05 PM

Stock events for Evolent Health, Inc. (EVH)

Evolent Health's stock price has significantly declined over the past year. Key events include a Q3 2025 earnings report where EPS missed estimates but revenue surpassed them, a less impressive Q4 2025 revenue guidance, the sale of Evolent Care Partners to Privia Health Group, Inc., and reports that Evolent Health was exploring a sale after receiving takeover inquiries.

Demand Seasonality affecting Evolent Health, Inc.’s stock price

There is no explicit information detailing the demand seasonality for Evolent Health, Inc.'s specific products and services. However, Evolent Health's demand has slowed significantly, with annualized revenue growth over the last two years being below its five-year trend.

Overview of Evolent Health, Inc.’s business

Evolent Health, Inc. is a healthcare technology and services company established in 2011, focused on simplifying healthcare and improving outcomes. They operate in the Healthcare Technology sector and the broader Healthcare industry, offering services to support health plans and provider organizations in value-based care models. Evolent Health Services provides an integrated platform for health plan administration and population health management, including Identifi, a proprietary technology system. Clinical Solutions offers specialty care management services, supporting the transition to value-based care with technology like the CarePro platform and Machinify Auth.

EVH’s Geographic footprint

Evolent Health serves national and regional health plans, integrated health systems, and physician groups across the United States. The company is headquartered in Arlington, Virginia.

EVH Corporate Image Assessment

Evolent Health is consistently recognized as a top place to work in healthcare nationally. No specific negative events directly impacting Evolent Health's brand reputation in the past year were found in the provided search results.

Ownership

Evolent Health, Inc. has a substantial number of institutional owners and shareholders, with 412 institutions holding a total of 153,741,786 shares. The majority of Evolent Health's outstanding shares are owned by other corporate entities. Major institutional owners include Cadian Capital Management, Lp, BlackRock, Inc., and Vanguard Group Inc.

Expert AI

Show me the sentiment for Evolent Health, Inc.
What's the latest sentiment for Evolent Health, Inc.?

Price Chart

$3.25

2.11%
(1 month)

Top Shareholders

Cadian Capital Management LP
9.44%
BlackRock, Inc.
8.80%
Morgan Stanley
7.90%
The Vanguard Group, Inc.
7.60%
UBS Group AG
5.46%
Eventide Asset Management LLC
5.36%
Rubicon Founders LLC
4.95%
Engaged Capital Holdings LLC
4.74%

Trade Ideas for EVH

Today

Sentiment for EVH

News
Social

Buzz Talk for EVH

Today

Social Media

FAQ

What is the current stock price of Evolent Health, Inc.?

As of the latest update, Evolent Health, Inc.'s stock is trading at $3.25 per share.

What’s happening with Evolent Health, Inc. stock today?

Today, Evolent Health, Inc. stock is down by -2.11%, possibly due to news.

What is the market sentiment around Evolent Health, Inc. stock?

Current sentiment around Evolent Health, Inc. stock is negative, based on recent news, trading volume, and analyst opinions.

Is Evolent Health, Inc.'s stock price growing?

Over the past month, Evolent Health, Inc.'s stock price has decreased by -2.11%.

How can I buy Evolent Health, Inc. stock?

You can buy Evolent Health, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol EVH

Who are the major shareholders of Evolent Health, Inc. stock?

Major shareholders of Evolent Health, Inc. include institutions such as Cadian Capital Management LP (9.44%), BlackRock, Inc. (8.80%), Morgan Stanley (7.90%) ... , according to the latest filings.